- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AJMC® in the Press, March 20, 2020
Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.
A piece on MEAWW.com, titled “Coronavirus pandemic: People with heart disease, diabetes have worst outcomes, should remain alert,” referenced a recent article published on AJMC.com, the website of The American Journal of Managed Care® (AJMC®). The article, “How Vulnerable Are Patients With Cardiovascular Disease to COVID-19, Flu Complications?,” indicated that while patients with cardiovascular disease are especially vulnerable to respiratory infections, uncertainty remains regarding just what damage COVID-19 can cause in these patients.
An article by Anchorage Daily News cited a piece published on AJMC.com in May 2019, “Violence Against Healthcare Workers: A Rising Epidemic.” The article noted that more attention needs to be brought to increasing rates of violence against employees in the field of healthcare, as 75% of nearly 25,000 workplace assaults occur annually in healthcare setting.
An article from AJMC®’s sister site, The Center for Biosimilars®, was featured in the March 18, 2019, daily regulatory news and intelligence briefing from Regulatory Focus. The article, “FDA Overseas Inspection Policy Is Concerning, Says Biosimilars Patent Attorney,” was included in the section Pharmaceuticals & Biotechnology.
Exploring Pharmaceutical Innovations, Trust, and Access With CVS Health's CMO
July 11th 2024On this episode of Managed Care Cast, we're talking with the chief medical officer of CVS Health about recent pharmaceutical innovations, patient-provider relationships, and strategies to reduce drug costs.
Listen
Opportunities and Obstacles Associated With the Medicare Diabetes Prevention Program
October 3rd 2025This study describes the current opportunities and obstacles associated with Medicare Diabetes Prevention Program implementation from the novel perspective of program suppliers across the US.
Read More
